Cite
Development of a tin oxide carrier with mesoporous structure for improving the dissolution rate and oral relative bioavailability of fenofibrate.
MLA
Bai, Andi, et al. “Development of a Tin Oxide Carrier with Mesoporous Structure for Improving the Dissolution Rate and Oral Relative Bioavailability of Fenofibrate.” Drug Design, Development and Therapy, vol. 12, July 2018, pp. 2129–38. EBSCOhost, https://doi.org/10.2147/DDDT.S166989.
APA
Bai, A., Wu, C., Liu, X., Lv, H., Xu, X., Cao, Y., Shang, W., Hu, L., & Liu, Y. (2018). Development of a tin oxide carrier with mesoporous structure for improving the dissolution rate and oral relative bioavailability of fenofibrate. Drug Design, Development and Therapy, 12, 2129–2138. https://doi.org/10.2147/DDDT.S166989
Chicago
Bai, Andi, Chao Wu, Xuan Liu, Huiling Lv, Xiaoyan Xu, Yue Cao, Wenjing Shang, Lili Hu, and Ying Liu. 2018. “Development of a Tin Oxide Carrier with Mesoporous Structure for Improving the Dissolution Rate and Oral Relative Bioavailability of Fenofibrate.” Drug Design, Development and Therapy 12 (July): 2129–38. doi:10.2147/DDDT.S166989.